Clinical Trial: CAR- PRISM (PRecision Intervention Smoldering Myeloma)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Multiple Myeloma
Study Type: INTERVENTIONAL
Official Title: CAR- PRISM (PRecision Intervention Smoldering Myeloma): A Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in High-Risk Smoldering Myeloma
Brief Summary:
The goal of this research study is to test if ciltacabtagene autoleucel (cilta-cel) is safe and effective in treating participants with high-risk, smoldering myeloma.The names of the treatment interventions used in this study are:Cilta-cel (or chimeric antigen receptor T cells)Cyclophosphamide (a lymphodepleting chemotherapy)Fludarabine (a lymphodepleting chemotherapy)
Read more